The CCK8 (Bimake) and EDU incorporation assays (Ribobio) were performed according to the manufacturers’ procedures. Cell viability was assessed by a CCK8 assay as previously described (25 (link)). The proliferation ability of astrocytoma cells was detected by an EDU incorporation assay as previously described (26 (link)). The invasive ability of astrocytoma cells was tested by a transwell assay (Corning Inc.) as previously described (25 (link)).
Free full text: Click here